Month: April 2026

EMERYVILLE, Calif., April 13, 2026 (GLOBE NEWSWIRE) — BioAge Labs, Inc. (NASDAQ: BIOA) (“BioAge”, “the Company”), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today announced that the Company will present at the 25th Annual Needham Virtual Healthcare Conference taking place April 13–16, 2026. Kristen Fortney, PhD, CEO and co-founder, is scheduled to participate in a fireside chat on Thursday, April 16 from 3:00 PM to 3:30 PM EDT. Kristen Fortney, Dov Goldstein, MD, CFO, and BJ Sullivan, PhD, Chief Strategy Officer, will participate in one-on-one meetings. To access the live webcast of the presentation, register here. Replays of the webcast will be available in the investor section of the Company’s website...

NEW YORK, April 13, 2026 (GLOBE NEWSWIRE) — Rezolve Ai PLC (NASDAQ: RZLV), the global leader in AI-native commerce infrastructure, today announced it will host an investor call and Q&A open to shareholders of both Rezolve Ai and Commerce.com, Inc. (NASDAQ: CMRC) on Wednesday, April 15, 2026, at 0800 Eastern Time. The call will be hosted by Daniel M. Wagner, Chairman and CEO of Rezolve Ai, and will follow the agenda below:Introduction to Rezolve Ai: the company, its technology platform and its financial trajectory Overview of the proposed combination with Commerce.com: the strategic rationale for the proposed offer The opportunity ahead: the value creation path and what it means for shareholders of both companies Open Q&ACommerce.com is guiding for as little as 1.5% revenue growth in the year ahead. Rezolve Ai is on...

WALTHAM, Mass., April 13, 2026 (GLOBE NEWSWIRE) — Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (Nasdaq: SYRE), a clinical-stage biotechnology company advancing best-in-class antibody engineering, dose optimization, and rational therapeutic combinations for the treatment of Inflammatory Bowel Disease (“IBD”) and other immune-mediated diseases, today announced that it has commenced an underwritten public offering of $300.0 million of shares of its common stock. In addition, the Company is expected to grant the underwriters of the offering an option for a period of 30 days to purchase an additional $45.0 million of shares of common stock at the public offering price, less the underwriting discount. All of the shares of common stock in the offering will be sold by Spyre. The offering is subject to market and other conditions,...

SAN RAFAEL, BULACAN, PHILIPPINES, April 13, 2026 (GLOBE NEWSWIRE) — One and one Green Technologies. INC (Nasdaq: YDDL) (“One and One” or the “Company”) (NASDAQ: YDDL), a Philippines-based recycler holding a government-issued license in the Philippines to import and process hazardous waste as raw materials, today announced the closing of its previously announced follow-on offering to two institutional investors for the sale of 1,733,334 units (the “Units”) in a follow-on offering of its securities at a purchase price of $7.50 per Unit, each unit consisting of one Class A ordinary share, par value $ 0.0001 per share (“Class A Ordinary Share”), and one warrant (“Warrant”) to purchase one and a half Class A Ordinary Shares (together, the “Securities”). The gross proceeds from the offering were $13 million, before deducting...

PORTLAND, Maine, April 13, 2026 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops and markets products to improve calf health and productivity, announced that Dr. Gilles Guillemette and Dr. Anthony DiMarco have been appointed to its Board of Directors, effective April 15, 2026. The Company also announced it is moving to a 7-person Board of Directors with six Independent Directors and the CEO, and that it will create a Strategy and Technology Committee of the Board of Directors. Dr. Guillemette has more than 30 years of executive experience in animal health therapeutics. He has held executive positions at Elanco, Bayer, Henry Schein, Chewy, and Trupanion, where he had significant P&L responsibilities, led strategy, business development and finance...

HOUSTON, April 13, 2026 (GLOBE NEWSWIRE) — Par Pacific Holdings, Inc. (NYSE: PARR) (“Par Pacific”) today announced that it will release its first quarter 2026 results after the New York Stock Exchange closes on Tuesday, May 5, 2026. This release will be followed by a conference call for investors on Wednesday, May 6, 2026, at 9:00 a.m. Central Time (10:00 a.m. Eastern). The full text of the release will be available on Par Pacific’s website at http://www.parpacific.com. Par Pacific First Quarter 2026 Earnings Conference CallWednesday, May 6, 20269:00 a.m. Central time (10:00 a.m. Eastern)Dial-in number: 1-833-974-2377 (toll-free) or 1-412-317-5782 (toll) Individuals who would like to participate should dial the applicable dial-in number at least 10 minutes before the scheduled conference call time. To access the live audio webcast...

BATON ROUGE, La., April 13, 2026 (GLOBE NEWSWIRE) — Lamar Advertising Company (Nasdaq: LAMR) will release its first quarter ended March 31, 2026 earnings report before the market opens on Thursday, May 7, 2026. Lamar will host a conference call on Thursday, May 7, 2026 at 8:00 a.m. (Central time) to discuss the Company’s results and answer questions relating to company operations. Instructions for dialing into Lamar’s conference call are provided below:All Callers: 1-800-420-1271 or 1-785-424-1634   Passcode: 63104   Live Webcast: ir.lamar.com   Webcast Replay: ir.lamar.com     Available through Thursday, May 14, 2026 at 11:59 p.m. Eastern timeCompany Contact: Buster Kantrow  Director of Investor Relations  (225) 926-1000  bkantrow@lamar.com

TORONTO, April 13, 2026 (GLOBE NEWSWIRE) — AGF Investments Inc. (AGF Investments) (TSX:AGF.B) today announced the appointment of John Porter as Chief Investment Officer (CIO), effective May 1, 2026. Mr. Porter brings decades of investment management and leadership experience across global markets and asset classes. He possesses deep expertise in portfolio management and extensive experience in retail and institutional asset management. In the role of CIO, Mr. Porter will be responsible for leading AGF Investments’ investment team, setting strategic priorities and continuing a culture of high performance and risk management. Further, he will work closely with each investment team to continue evolving the firm’s capabilities, supporting long-term growth. Mr. Porter will report to AGF Management Limited’s Chief Executive Officer (CEO),...

PANAMA CITY, April 13, 2026 (GLOBE NEWSWIRE) — Copa Holdings, S.A. (NYSE: CPA) today released preliminary passenger traffic statistics for March 2026:Copa Holdings (Consolidated) March 2026 March 2025 % ChangeASM (mm) (1) 3,025.7   2,636.7           14.8 %  RPM (mm) (2) 2,623.5   2,274.6           15.3 %Load Factor (3)         86.7 %         86.3 %         0.4p.p.           Available seat miles – represents the aircraft seating capacity multiplied by the number of miles the seats are flown. Revenue passenger miles – represents the number of miles flown by revenue passengers Load factor – represents the percentage of aircraft seating capacity that is utilizedFor March 2026, Copa Holdings’ capacity (ASMs) increased by 14.8%, while system-wide passenger traffic (RPMs) increased by 15.3%...